ArticleJournal of immunology (Baltimore, Md. : 1950)2026
Dual T cell receptor expression provides intrinsic advantage for agonist selection of thymic FoxP3+ regulatory T cells (Tregs) in the neonatal thymus.
Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Co-expression of 2 T cell receptor (TCR) clonotypes due to allelic inclusion occurs in ∼16% of peripheral blood T cells in mice and humans. Evidence indicates dual TCR expression can affect thymic development and peripheral function. Notably, dual TCR cells demonstrate increased reactivity against self-antigens and heightened TCR signaling, properties that could favor development of FoxP3+ regulatory CD4+ T cells (Tregs). However, the impact of dual TCR expression on Treg development remains controversial. We hypothesize that this discrepancy arises from 2 opposing factors: While dual TCR expression enhances TCR signal strength and promotes agonist selection into the Treg lineage, the capacity of the thymic Treg niche may impose extrinsic limitations that obscure this effect. To test this hypothesis, we utilized the B6.TCRA-GFP/RFP reporter model, which enables precise identification of single and dual TCRα-expressing cells. We found that dual TCR expression is associated with increased frequencies of thymic Tregs in neonatal (day 10) mice, an age characterized by robust Treg output, but not in adults. In both age groups, dual TCR Tregs exhibited elevated expression of Nur77, consistent with stronger TCR signaling during selection. However, in adult mice, the presence of recirculating peripheral Tregs reduces niche availability, thereby diminishing the selection advantage conferred by dual TCR expression. These findings reveal a previously underappreciated role for dual TCR expression in shaping thymic Treg development and provide insight into mechanisms of self-tolerance in neonates and in settings such as hematopoietic stem cell transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.